OpenURL Connection Search

Select item for more details and to access through your institution.

FGF21 gene therapy as treatment for obesity and insulin resistance.
Published in:
EMBO Molecular Medicine, 2018, v. 10, n. 8, p. 1, doi. 10.15252/emmm.201708791
By:
- Jimenez, Veronica;
- Jambrina, Claudia;
- Casana, Estefania;
- Sacristan, Victor;
- Muñoz, Sergio;
- Darriba, Sara;
- Rodó, Jordi;
- Mallol, Cristina;
- Garcia, Miquel;
- León, Xavier;
- Marcó, Sara;
- Ribera, Albert;
- Elias, Ivet;
- Casellas, Alba;
- Grass, Ignasi;
- Elias, Gemma;
- Ferré, Tura;
- Motas, Sandra;
- Franckhauser, Sylvie;
- Mulero, Francisca
Publication type:
Article
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy.
Published in:
2013
By:
- Haurigot, Virginia;
- Marcó, Sara;
- Ribera, Albert;
- Garcia, Miguel;
- Ruzo, Albert;
- Villacampa, Pilar;
- Ayuso, Eduard;
- Añor, Sònia;
- Andaluz, Anna;
- Pineda, Mercedes;
- García-Fructuoso, Gemma;
- Molas, Maria;
- Maggioni, Luca;
- Muñoz, Sergio;
- Motas, Sandra;
- Ruberte, Jesús;
- Mingozzi, Federico;
- Pumarola, Martí;
- Bosch, Fatima
Publication type:
journal article
Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.
Published in:
Human Molecular Genetics, 2017, v. 26, n. 8, p. 1535, doi. 10.1093/hmg/ddx058
By:
- Roca, Carles;
- Motas, Sandra;
- Marcó, Sara;
- Ribera, Albert;
- Sánchez, Víctor;
- Sánchez, Xavier;
- Bertolin, Joan;
- León, Xavier;
- Pérez, Jennifer;
- Garcia, Miguel;
- Villacampa, Pilar;
- Ruberte, Jesús;
- Pujol, Anna;
- Haurigot, Virginia;
- Bosch, Fatima
Publication type:
Article
Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy.
Published in:
Human Molecular Genetics, 2015, v. 24, n. 7, p. 2078, doi. 10.1093/hmg/ddu727
By:
- Ribera, Albert;
- Haurigot, Virginia;
- Garcia, Miguel;
- Marcó, Sara;
- Motas, Sandra;
- Villacampa, Pilar;
- Maggioni, Luca;
- León, Xavier;
- Molas, Maria;
- Sánchez, Víctor;
- Muñoz, Sergio;
- Leborgne, Christian;
- Moll, Xavier;
- Pumarola, Martí;
- Mingozzi, Federico;
- Ruberte, Jesús;
- Añor, Sònia;
- Bosch, Fatima
Publication type:
Article

Found: 4

FGF21 gene therapy as treatment for obesity and insulin resistance.

Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy.

Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.

Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy.